KR
Kandhagatla Rajnarayana
About Kandhagatla Rajnarayana
Data last updated:
Kandhagatla Rajnarayana is a Director at Anwita Drugs & Chemicals Private Limited (since 2014) and Director at Synerzys Novaceuticals Private Limited (since 2015). The companies operate in Pharma, Chemicals and Materials and FMCG. The 2 current companies with reported revenue have a combined latest revenue of ₹20.53 Cr; the largest is Anwita Drugs & Chemicals Private Limited at ₹20.49 Cr (FY 2024). Earlier, Kandhagatla Rajnarayana was a Director at Glukem Pharmaceuticals Private Limited (2009–2013) and Director at Maven Life Sciences Private Limited (2010) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Anwita Drugs & Chemicals Private Limited U24232TG2014PTC092897 | Director | 12 Feb 2014 | 2014 | ₹20.49 Cr (FY 2024) | Active |
 Synerzys Novaceuticals Private Limited U24100TG2015PTC098988 | Director | 20 May 2015 | 2015 | ₹4 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Glukem Pharmaceuticals Private Limited U24233TG2009PTC062750 | Director | 10 Feb 2009 | 2009 | Active | |
| Maven Life Sciences Private Limited U24232TG2010PTC068613 | Director | 28 May 2010 | 2010 | Active | |
| Mak Labs Private Limited U24232TG2014PTC092264 | Director | 09 Jan 2014 | 2014 | ₹7.4 Lakh (FY 2020) | Active |
| Amirit Laboratories Private Limited U24232TG2010PTC067892 | Director | 09 Apr 2010 | 2010 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kandhagatla Rajnarayana
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kandhagatla Shiva Vara Prasad | 08033555 | Anwita Drugs & Chemicals Private Limited | Director |
| Kaushal Kirtikumar Shah | 03413801 | Synerzys Novaceuticals Private Limited | Director |
| Nazneen Hamid | 03248669 | Synerzys Novaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kandhagatla Rajnarayana
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kandhagatla Rajnarayana
Kandhagatla Rajnarayana currently holds 2 directorships: Anwita Drugs & Chemicals Private Limited (Director, since 12 Feb 2014, revenue ₹20.49 Cr (FY 2024)); Synerzys Novaceuticals Private Limited (Director, since 20 May 2015, revenue ₹4 Lakh (FY 2024)).
Kandhagatla Rajnarayana was first appointed on 10 Feb 2009 as Director at Glukem Pharmaceuticals Private Limited. The most recent appointment on record is 20 May 2015 at Synerzys Novaceuticals Private Limited.
The 2 current companies of Kandhagatla Rajnarayana that report revenue have a combined latest revenue of ₹20.53 Cr: Anwita Drugs & Chemicals Private Limited ₹20.49 Cr (FY 2024); Synerzys Novaceuticals Private Limited ₹4 Lakh (FY 2024).
Kandhagatla Rajnarayana held 4 earlier board appointments: Glukem Pharmaceuticals Private Limited (Director, 10 Feb 2009 to 05 Sep 2013); Maven Life Sciences Private Limited (Director, 28 May 2010 to 26 Aug 2010); Mak Labs Private Limited (Director, 09 Jan 2014 to 01 Feb 2014); Amirit Laboratories Private Limited (Director, from 09 Apr 2010).
The current boards of Kandhagatla Rajnarayana's companies include Kandhagatla Shiva Vara Prasad (Anwita Drugs & Chemicals Private Limited), Kaushal Kirtikumar Shah (Synerzys Novaceuticals Private Limited), Nazneen Hamid (Synerzys Novaceuticals Private Limited).